Comparative Pharmacology
Head-to-head clinical analysis: NOVAMINE 15 versus NOVAMINE 8 5.
Peer-Reviewed Evidence
Head-to-head clinical analysis: NOVAMINE 15 versus NOVAMINE 8 5.
NOVAMINE 15% vs NOVAMINE 8.5%
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Amino acids solution providing essential and non-essential amino acids for protein synthesis, tissue repair, and maintenance of nitrogen balance.
Novamine 8.5% is a crystalline amino acid solution that provides essential and non-essential amino acids for protein synthesis and nitrogen balance in patients who cannot obtain adequate nutrition enterally.
Intravenous infusion. Adults: 1-2 g/kg/day of amino acids, adjusted based on metabolic needs, clinical status, and nitrogen balance. Typical infusion rate: 100-200 mL/hour of 15% solution (0.15-0.3 g/kg/hour).
500 mL to 2000 mL intravenously per 24 hours, typically infused at a rate of 20 to 40 mL/hour; adjust based on metabolic and clinical response.
None Documented
None Documented
Variable; amino acid half-lives range from minutes to hours depending on individual amino acid. Clinical context: continuous infusion achieves steady state within 24 hours in normal renal function.
Variable; amino acids have short t1/2 of minutes to hours. Clinical context: continuous infusion maintains steady state; elimination depends on metabolic demand and organ function.
Amino acids are metabolized; nitrogen is excreted primarily as urea in urine (80% of nitrogen), with minimal fecal elimination (<5%).
Renal: >95% as amino acids and metabolites. Biliary/fecal: <5%.
Category C
Category C
Parenteral Nutrition
Parenteral Nutrition